HIT Consultant November 19, 2024
Fred Pennic

What You Should Know:

Synapticure, a virtual care company focused on neurodegenerative diseases secures $25M in a Series A funding round led by B Capital, the investment includes participation from new investors CommonSpirit Health, CVS Health Ventures, RA Capital Management, and Nexus NeuroTech Ventures, as well as existing investors Google Ventures, Optum Ventures, and Rock Health Capital.

– Founded by individuals with firsthand experience navigating the challenges of neurodegenerative diseases, Synapticure is deeply committed to patient- and caregiver-centric care. The company’s mission is to transform the lives of millions affected by these conditions by providing accessible, comprehensive, and compassionate care.

Addressing the Growing Need for Neurodegenerative Care

Co-founded by patient and caregiver Brian Wallach and Sandra Abrevaya, Synapticure...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Investments, Technology, Trends
Unlocking the power of sensor data in type 2 diabetes care
AI Agents: The Transformative Architects Of The Digital Age
Healthcare’s Hottest Trends: AI, Layoffs, and a Measles Comeback Tour
‘Innovation Out of Necessity’: Why Virtual Care Is Crucial for Rural Providers
Vitalchat Secures Series A Funding Led by GHC Industries to Scale Virtual Nursing and Telehealth Solutions

Share This Article